JHS Svendgaard Laboratories Schedules Board Meeting for Q2 FY27 Financial Results
JHS Svendgaard Laboratories Ltd 路 Intimation 路 02 Nov 2026, 5:30 am
JHS Svendgaard Laboratories Schedules Board Meeting for Q2 FY27 Financial Results JHS Svendgaard Laboratories Limited has scheduled its Board of Directors meeting for 2nd Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the company's trading window closed on 1st Oct'26 and will remain shut until 48 hours following the official announcement of the financial results.
Original exchange filing (PDF)
More announcements from JHS Svendgaard Laboratories Ltd
- Un-Audited Financial Results for the Quarter and Half year Ended 30th September, 2026. 路 04 Nov 2026
- Un-Audited Financial Results for the Quarter and Half Year Ended 30th September, 2026 路 04 Nov 2026
- Statement of Deviation and Variation for the quarter ended 30 September, 2026. 路 03 Nov 2026
- Board of Directors approved the appointment of Mr. Pardeep Kumar Bhardwaj as an Additional Non-Executive Independent Director of the Company. 路 03 Nov 2026
- Board of Directors in their meeting dated 02 November, 2026 approved the unaudited Standalone and Consolidated financials for quarter and half year ended 30 September, 2026. 路 03 Nov 2026
- JHS Svendgaard Laboratories Limited has submitted to the Exchange, Un-audited-financial results for the period ended September 30, 2026. 路 02 Nov 2026
- Board of Directors approved the unaudited standalone and consolidated financials for quarter and half year ended 30 September, 2026. 路 02 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 02 Nov 2026
